SUPRAFLEX CRUZ PMCF Study ( rEpic05 )

NCT05617599 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 508

Last updated 2025-12-16

No results posted yet for this study

Summary

Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Medical Device Regulations (MDR) with multivessel coronary disease requirements in all the CONSECUTIVE patients treated with (SUPRAFLEX CRUZ).

Conditions

  • Coronary Artery Disease (CAD)
  • Ischemic Heart Disease

Interventions

DEVICE

SUPRAFLEX CRUZ

Patients in whom treatment with SUPRAFLEX CRUZ has been attempted

Sponsors & Collaborators

  • Fundación EPIC

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-10
Primary Completion
2026-12-01
Completion
2026-12-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05617599 on ClinicalTrials.gov